These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 30564886)

  • 1. Cannabis and mental illness: a review.
    Lowe DJE; Sasiadek JD; Coles AS; George TP
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):107-120. PubMed ID: 30564886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis Associated Mental Health Effects: A Review.
    Kancherla N; Jeyanthi KM; Abbas R; Sathi TSCR; Upadhyay A; Garlapati SKP
    J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S943-S946. PubMed ID: 35017903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use and mood disorders: a systematic review.
    Sorkhou M; Dent EL; George TP
    Front Public Health; 2024; 12():1346207. PubMed ID: 38655516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and Depression.
    Feingold D; Weinstein A
    Adv Exp Med Biol; 2021; 1264():67-80. PubMed ID: 33332004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Marijuana Use in Patients with Orthopaedic Trauma.
    Sheppard SG; Wall PV; Wheatley B; Kent W
    JBJS Rev; 2021 Dec; 9(12):. PubMed ID: 35102050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Construct of Medical and Non-Medical Marijuana-Critical Review.
    Silczuk A; Smułek D; Kołodziej M; Gujska J
    Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and their therapeutic applications in mental disorders
.
    Scherma M; Muntoni AL; Riedel G; Fratta W; Fadda P
    Dialogues Clin Neurosci; 2020 Sep; 22(3):271-279. PubMed ID: 33162770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies.
    Ayoub SM; Holloway BM; Miranda AH; Roberts BZ; Young JW; Minassian A; Ellis RJ
    Curr HIV/AIDS Rep; 2024 Jun; 21(3):87-115. PubMed ID: 38602558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review.
    Roncero C; Valriberas-Herrero I; Mezzatesta-Gava M; Villegas JL; Aguilar L; Grau-López L
    Reprod Health; 2020 Feb; 17(1):25. PubMed ID: 32066469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada - A Qualitative Study.
    Das A; Hendershot CS; Husain MI; Knyahnytska Y; Elsaid S; Le Foll B; Kloiber S
    Pharmacopsychiatry; 2024 May; 57(3):141-151. PubMed ID: 38467156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment.
    Stark T; Di Martino S; Drago F; Wotjak CT; Micale V
    Pharmacol Res; 2021 Dec; 174():105938. PubMed ID: 34655773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Adolescent Exposure to Cannabinoids and Early Adverse Experience Interact to Increase the Risk of Psychiatric Disorders: Evidence from Rodent Models.
    Portugalov A; Akirav I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research.
    Kayser RR; Haney M; Simpson HB
    Front Psychiatry; 2021; 12():626150. PubMed ID: 33716825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models.
    Jenkins BW; Khokhar JY
    Front Psychiatry; 2021; 12():597725. PubMed ID: 33613338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping.
    al'Absi M; Allen AM
    Front Psychol; 2021; 12():687106. PubMed ID: 34276511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Persons Registrated Due to Cannabinoid Abuse in Croatia - Do We Have enough Effective Intervention?
    Milaković D; Štimac Grbić D; Valentić M; Vuletić G; Pavić Šimetin I
    Psychiatr Danub; 2021; 33(4):541-550. PubMed ID: 34928902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric Structures in Mental Illnesses-"Magic" Molecules Specified for Complex Disorders.
    Kleczkowska P
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental finding of age and time disorientation in a clinical sample of patients with schizophrenia: Findings from a short term follow up survey regarding cannabis use.
    Zhand N; Osborne R; Stuyt M; Hatko A; Friberg L; Rouabhi A; Attwood D
    Psychiatry Res; 2020 Aug; 290():113150. PubMed ID: 32540587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraising prazosin for night-time symptoms in post-traumatic stress disorder.
    Maguire PA; Looi JC
    Aust N Z J Psychiatry; 2020 Aug; 54(8):848-849. PubMed ID: 32114767
    [No Abstract]   [Full Text] [Related]  

  • 20. A case study for the use of medical cannabis in generalized anxiety disorder.
    Walkaden C
    Discoveries (Craiova); 2019 Jun; 7(2):e92. PubMed ID: 32309610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.